<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6631769\results\search\disease\results.xml">
  <result pre="caused by human-to-human or animal-to-human transmissible viral pathogens. Annually, seasonal" exact="influenza" post="epidemics attack human populations leading to 290–650 thousand deaths/year"/>
  <result pre="fusion protein of the H1-type haemagglutinin (HA) of the pandemic" exact="influenza" post="A virus (H1N1) strain from 2009 (H1N1pdm09) and the"/>
  <result pre="reliable approach to protect against two different viral infections. OMVs" exact="influenza" post="vaccine MERS-CoV H1N1pdm 1. Introduction Acute respiratory infections are"/>
  <result pre="millions of human deaths worldwide each year [3]. Annually, seasonal" exact="influenza" post="epidemics attack 10–20% of the human population leading to"/>
  <result pre="world is confronted every 10–40 years with antigenically distinct pandemic" exact="influenza" post="virus strains of wide geographical distribution and considerable human-to-human"/>
  <result pre="recent years, the world has been challenged with newly emerging" exact="influenza" post="A virus (IAV) infections, which have the potential to"/>
  <result pre="the human population within limited epidemics. For instance, highly pathogenic" exact="avian influenza" post="viruses (HPAIV) of the H5N1-subtype and low pathogenic avian"/>
  <result pre="human population within limited epidemics. For instance, highly pathogenic avian" exact="influenza" post="viruses (HPAIV) of the H5N1-subtype and low pathogenic avian"/>
  <result pre="avian influenza viruses (HPAIV) of the H5N1-subtype and low pathogenic" exact="avian influenza" post="viruses (LPAIV) of the H7N9-, H10N8- and H6N1-subtypes [6,7,8,9]"/>
  <result pre="influenza viruses (HPAIV) of the H5N1-subtype and low pathogenic avian" exact="influenza" post="viruses (LPAIV) of the H7N9-, H10N8- and H6N1-subtypes [6,7,8,9]"/>
  <result pre="caused global pandemic outbreaks, such as the 2009 swine-origin H1N1" exact="influenza" post="virus (H1N1pdm09) [10,11]. In 2012, a novel Middle East"/>
  <result pre="viral HA1 protein was achieved using rabbit monoclonal antibodies recognizing" exact="influenza" post="A virus hemagglutinin (Abcam), diluted 1:1000 in blocking buffer."/>
  <result pre="weight (2 μg/g). An infectious dose of 105.5 TCID50 of" exact="influenza" post="virus A/California/04/2009 (H1N1) wild type, was administered intra-nasally to"/>
  <result pre="were performed according to Egyptian regulations for the propagation of" exact="influenza" post="viruses. All experiments involving low pathogenic and highly pathogenic"/>
  <result pre="influenza viruses. All experiments involving low pathogenic and highly pathogenic" exact="avian influenza" post="A viruses were performed in biosafety level 2 and"/>
  <result pre="viruses. All experiments involving low pathogenic and highly pathogenic avian" exact="influenza" post="A viruses were performed in biosafety level 2 and"/>
  <result pre="humoral and cellular neutralizing antibody (nAb) immune responses [26,27,28,29,30,31]. Traditionally," exact="influenza" post="vaccines are produced by generating a natural or recombinant"/>
  <result pre="address additional vaccines needed to combat seasonal H1N1, H3N2 and" exact="influenza" post="B viruses. OMVs had been introduced as a part"/>
  <result pre="responses in animal models from diverse microorganisms such as N." exact="meningitis" post="B, Vibrio cholera, Salmonella Typhimurium, Pseudomonas aeruginosa, Gallibacterium anatis,"/>
  <result pre="Gallibacterium anatis, Acinetobacter baumannii, Chlamydia trachomatis, Shigella spp., and Mycobacterium" exact="tuberculosis" post="[35,36,37,38,39,40,41]. LPS in the outer surface of OMVs acts"/>
  <result pre="the immunogenicity and produce antiviral innate immune responses against various" exact="influenza" post="virus infections via activation of macrophages [42,43,44]. Despite that"/>
  <result pre="OMVs-H1/RBD produced high levels of a neutralizing Abs titer against" exact="influenza" post="H1N1 virus at 8 weeks post immunization. Stimulated neutralizing"/>
  <result pre="stable chimeric fusion protein of H1-type HA of the pandemic" exact="influenza" post="A virus (H1N1) strain and RBD of MERS-CoV induces"/>
  <result pre="flu infects humans for the first timeBMJ2013346f215110.1136/bmj.f215123558347 7.BahgatM.M.KutkatM.A.NasraaM.H.MostafaA.WebbyR.BahgatI.M.AliM.A.Characterization of an" exact="avian influenza" post="virus H5N1 Egyptian isolateJ. Virol. Methods.200915924425010.1016/j.jviromet.2009.04.00819406157 8.ChenH.YuanH.GaoR.ZhangJ.WangD.XiongY.FanG.YangF.LiX.ZhouJ.et al.Clinical and"/>
  <result pre="infects humans for the first timeBMJ2013346f215110.1136/bmj.f215123558347 7.BahgatM.M.KutkatM.A.NasraaM.H.MostafaA.WebbyR.BahgatI.M.AliM.A.Characterization of an avian" exact="influenza" post="virus H5N1 Egyptian isolateJ. Virol. Methods.200915924425010.1016/j.jviromet.2009.04.00819406157 8.ChenH.YuanH.GaoR.ZhangJ.WangD.XiongY.FanG.YangF.LiX.ZhouJ.et al.Clinical and"/>
  <result pre="8.ChenH.YuanH.GaoR.ZhangJ.WangD.XiongY.FanG.YangF.LiX.ZhouJ.et al.Clinical and epidemiological characteristics of a fatal case of" exact="avian influenza" post="A H10N8 virus infection: A descriptive studyLancet201438371472110.1016/S0140-6736(14)60111-224507376 9.ShiW.ShiY.WuY.LiuD.GaoG.F.Origin and"/>
  <result pre="al.Clinical and epidemiological characteristics of a fatal case of avian" exact="influenza" post="A H10N8 virus infection: A descriptive studyLancet201438371472110.1016/S0140-6736(14)60111-224507376 9.ShiW.ShiY.WuY.LiuD.GaoG.F.Origin and"/>
  <result pre="descriptive studyLancet201438371472110.1016/S0140-6736(14)60111-224507376 9.ShiW.ShiY.WuY.LiuD.GaoG.F.Origin and molecular characterization of the human-infecting H6N1" exact="influenza" post="virus in TaiwanProtein Cell2013484685310.1007/s13238-013-3083-024136722 10.LesslerJ.ReichN.G.CummingsD.A.NairH.P.JordanH.T.ThompsonN.Outbreak of 2009 pandemic influenza"/>
  <result pre="H6N1 influenza virus in TaiwanProtein Cell2013484685310.1007/s13238-013-3083-024136722 10.LesslerJ.ReichN.G.CummingsD.A.NairH.P.JordanH.T.ThompsonN.Outbreak of 2009 pandemic" exact="influenza" post="A (H1N1) at a New York City schoolN. Engl."/>
  <result pre="Engl. J. Med.20093612628263610.1056/NEJMoa090608920042754 11.NeumannG.NodaT.KawaokaY.Emergence and pandemic potential of swine-origin H1N1" exact="influenza" post="virusNature200945993193910.1038/nature0815719525932 12.Middle East Respiratory Syndrome Coronavirus (MERS-CoV)Available online: https://www.who.int/emergencies/mers-cov/en/(accessed"/>
  <result pre="ThreatViruses2018109310.3390/v10020093 14.MostafaA.PleschkaS.Influenza H3N2 Vaccines: Recent ChallengesTrends Microbiol.201710.1016/j.tim.2017.12.00329268980 15.ZostS.J.ParkhouseK.GuminaM.E.KimK.Diaz PerezS.WilsonP.C.TreanorJ.J.SantA.J.CobeyS.HensleyS.E.Contemporary H3N2" exact="influenza" post="viruses have a glycosylation site that alters binding of"/>
  <result pre="16.WuN.C.ZostS.J.ThompsonA.J.OyenD.NycholatC.M.McBrideR.PaulsonJ.C.HensleyS.E.WilsonI.A.A structural explanation for the low effectiveness of the seasonal" exact="influenza" post="H3N2 vaccinePLoS Pathogens201713e100668210.1371/journal.ppat.100668229059230 17.GerritzenM.J.H.MartensD.E.WijffelsR.H.van der PolL.StorkM.Bioengineering bacterial outer membrane"/>
  <result pre="lumenJ. Extracell Vesicles2014310.3402/jev.v3.24015 21.MostafaA.KanraiP.ZiebuhrJ.PleschkaS.Improved dual promotor-driven reverse genetics system for" exact="influenza" post="virusesJ. Virol. Methods201319360361010.1016/j.jviromet.2013.07.02123886561 22.BommakantiG.CitronM.P.HeplerR.W.CallahanC.HeideckerG.J.NajarT.A.LuX.JoyceJ.G.ShiverJ.W.CasimiroD.R.et al.Design of an HA2-based Escherichia"/>
  <result pre="Virol. Methods201319360361010.1016/j.jviromet.2013.07.02123886561 22.BommakantiG.CitronM.P.HeplerR.W.CallahanC.HeideckerG.J.NajarT.A.LuX.JoyceJ.G.ShiverJ.W.CasimiroD.R.et al.Design of an HA2-based Escherichia coli expressed" exact="influenza" post="immunogen that protects mice from pathogenic challengeProc. Natl. Acad."/>
  <result pre="coronavirus: A comprehensive reviewFront. Med.20161012013610.1007/s11684-016-0430-626791756 32.MostafaA.KanraiP.ZiebuhrJ.PleschkaS.The PB1 segment of an" exact="influenza" post="A virus H1N1 2009pdm isolate enhances the replication efficiency"/>
  <result pre="virus H1N1 2009pdm isolate enhances the replication efficiency of specific" exact="influenza" post="vaccine strains in cell culture and embryonated eggsJ. Gen."/>
  <result pre="the conserved hemagglutinin stalk domain and its prospects for universal" exact="influenza" post="vaccine developmentBiomed. Res. Int.201410.1155/2014/546274 34.LynchM.Evolution of the mutation rateTrends"/>
  <result pre="using DODAB-BF as adjuvant with outer membrane vesicles of Neisseria" exact="meningitis" post="BImmunobiology201810.1016/j.imbio.2018.07.02130055864 40.PerssonG.PorsS.E.ThofnerI.C.N.BojesenA.M.Vaccination with outer membrane vesicles and the fimbrial"/>
  <result pre="Immunology20189250110.3389/fimmu.2018.0250130459769 50.RappazzoC.G.WatkinsH.C.GuarinoC.M.ChauA.LopezJ.L.DeLisaM.P.LeiferC.A.WhittakerG.R.PutnamD.Recombinant m2e outer membrane vesicle vaccines protect against lethal" exact="influenza" post="a challenge in balb/c miceVaccine2016341252125810.1016/j.vaccine.2016.01.02826827663 51.WatkinsH.C.RappazzoC.G.HigginsJ.S.SunX.BrockN.ChauA.MisraA.CannizzoJ.P.B.KingM.R.MainesT.R.et al.Safe Recombinant Outer"/>
 </snippets>
</snippetsTree>
